The Royal Pharmaceutical Society (RPS) is supportive of the Government’s decision to offer one dose of the Covid-19 vaccine to school children between the ages of 12 to 15 from today (20 September).   In a statement published on its website today, the RPS said it believed the ‘health benefits [of offering the vaccine to this cohort] are marginally... Read more The post Vaccinating children will benefit them and ‘wider population’, says RPS appeared first on The Pharmacist.

Putting dispensing practices at the forefront of change in Primary care The PAMAN System and Service A remote monitoring, medication

Royal Pharmaceutical Society has expressed its support for the government’s Covid-19 vaccination programme for under 16s that began today, and sought advice on further dosage. Children in the age bracket of 12 and 15 years will be offered a single shot of the Pfizer/BioNTech Covid-19 vaccine following the government’s acceptance of the UK Chief Medical The post RPS supports Covid-19 vaccination programme for under 16s first appeared on Latest Pharmacy News | Business | Magazine - Pharmacy Business.

Community pharmacies in Northern Ireland have been commissioned to deliver the flu vaccine to all adults over 50 this coming winter, as well as health and social care workers.    It follows the pharmacy network’s successful delivery of the previous flu vaccination service, with almost 16,000 people vaccinated in last year’s campaign.   In a letter sent... Read more The post NI: Community pharmacies to offer flu vaccines to over 50s  appeared first on The Pharmacist.

Thousands of vulnerable NHS patients in hospital due to COVID-19 are set to benefit from a ground-breaking new antibody treatment Ronapreve. The drug is the first neutralising antibody medicine specifically designed to treat COVID-19 to be authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) for use in the UK. Ronapreve, a combination of

Recently reported experience of two women who were unable to get emergency contraception from their local pharmacy invoked serious criticism from the Royal Pharmaceutical Society president professor Claire Anderson. The report was featured by BBC3 online. Calling it “completely unacceptable”, Anderson said: “It’s vital women needing emergency contraception are not put off approaching their local The post RPS: Pharmacy refusal to provide emergency contraception is ‘completely unacceptable’ first appeared on Latest Pharmacy News | Business | Magazine - Pharmacy Business.

NICE and Public Health England have jointly released a guideline on Mental Wellbeing at Work, recommending mental health training for pharmacy managers and employers. The guideline has been prepared by an independent committee, comprising of mental health experts, employers, professionals from across the NHS, local authority members, and lay members. It covers creation of right The post NICE, PHE recommend ‘mental wellbeing’ training at work first appeared on Latest Pharmacy News | Business | Magazine - Pharmacy Business.

The Royal Pharmaceutical Society (RPS) has condemned the decision of pharmacists who refused to supply emergency contraception, labelling the action as ‘completely unacceptable’. Earlier this week, BBC Three reported the cases of three females under the age of 18 who had all been refused the morning-after pill at pharmacies. All three say they were refused... Read more The post Pharmacists’ refusal to give emergency contraception ‘completely unacceptable’ says RPS appeared first on The Pharmacist.

The NHS started delivering Covid-19 booster vaccines to people in eligible groups of over-50s from Thursday (September 16). Following the new advice by the Joint Committee on Vaccination and Immunisation (JCVI), the NHS vaccination programme will now invite eligible people, who had their second Covid jab at least six months ago, for a top up. The post NHS begins Covid-19 booster jab programme first appeared on Latest Pharmacy News | Business | Magazine - Pharmacy Business.

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a 10-week consultation process on future of medical device regulation, asking the general public to share their experience and contribute to regulatory framework. It has also asked people across the medical devices and healthcare sectors, medical practitioners and patients to share their views. Currently, medical The post Regulator launches consultation on future of medical device regulation first appeared on Latest Pharmacy News | Business | Magazine - Pharmacy Business.

New Directions Pharmacy, one of the leading pharmacy agencies in the UK, is organising a series of free sign language webinars for pharmacists to help overcome barriers to communication. The online programme, which will be held over the next two months, is free of charge to anyone working within the pharmacy sector. Its ‘Introduction to The post Free sign language training for pharmacists first appeared on Latest Pharmacy News | Business | Magazine - Pharmacy Business.

The Centre for Pharmacy Postgraduate Education (CPPE) has launched a programme for pharmacists which will acts as a first step in their professional development journey and support their springboard towards independent prescribing training The 12-month programme is open to pharmacists and locums who completed pre-registration training in the 2020-21 and are working in independent or The post CPPE launches a 12-month programme for new pharmacists first appeared on Latest Pharmacy News | Business | Magazine - Pharmacy Business.

Maggie Throup has been appointed as the new parliamentary under-secretary of state for prevention, public health and primary care with responsibilities for pharmacy at the Department of Health and Social Care (DHSC). As of today  (17 September), Ms Throup, an MP for Erewash, who was previously a Government whip, replaced Jo Churchill who took up... Read more The post Government appoints Maggie Throup as new pharmacy minister appeared first on The Pharmacist.

Pharmaceutical Services Negotiating Committee chief executive Simon Dukes has assured that all pharmacy contractors will receive payments for their Covid-related costs early next month with the “overwhelming majority” getting paid in full. “At the start of October, we expect that every single contractor will receive a payment from NHS BSA (NHS Business Services Authority)” with The post PSNC chief Dukes assures contractors will receive Covid-related payments early October first appeared on Latest Pharmacy News | Business | Magazine - Pharmacy Business.

Maggie Throup, the Conservative Party MP for Erewash, is the new minister with responsibility for pharmacy. She was appointed parliamentary under secretary of state for Prevention, Public Health and Primary Care on Thursday (September 16) following a cabinet reshuffle by prime minister Boris Johnson which saw her predecessor Jo Churchill moved to Defra. “Honoured to The post BREAKING: Can’t wait to get stuck into my new role, says new pharmacy minister Maggie Throup first appeared on Latest Pharmacy News | Business | Magazine - Pharmacy Business.

Winners from the 12th PM Society Digital Awards have been announced after the event was held online for the second year in a row, due to the pandemic. The Awards celebrate the best in digital communications within the pharmaceutical and healthcare sectors and judges include experts from digital, creative and communications agencies, digital specialists and

The Royal Pharmaceutical Society (RPS) has called for free flu vaccinations for pharmacists in England and Wales, saying it’s “shocking” that they are not eligible despite working on the frontline throughout the coronavirus pandemic. The RPS has urged the NHS to offer free flu jabs for all pharmacists following reports that pharmacy teams across primary The post Shocking pharmacists in England and Wales are not eligible, says RPS as it demands free flu jabs for pharmacy teams first appeared on Latest Pharmacy News | Business | Magazine - Pharmacy Business.

A new coalition with members from Royal Colleges, health charities and patient groups has come together to ensure the interests of patients are at the heart of the development of policy in digital health technology. The Patient Coalition for AI, Data and Digital Tech in Health is the first coalition to unite such a diverse range

Medical Science Liaison (MSL) teams in the pharma industry were already at the limit pre-Covid. Products were complex, wider engagement from healthcare professionals (HCPs) was expected as standard, and Key Opinion Leaders (KOLs) that MSLs needed to engage were time pressed. Now, due to Covid-shortened timelines, the pressure is intensifying. As pharma companies look to

Sandoz, a Novartis division, has strengthened its pipeline by entering into a commercialization agreement with Bio-Thera Solutions, Ltd. for biosimilar bevacizumab (BAT1706) for the treatment of multiple types of cancers. Bevacizumab is a recombinant humanized monoclonal IgG1 antibody that targets vascular endothelial growth factor (VEGF), a key mediator of angiogenesis in cancer, and is used

The Health and Social Care Secretary has announced that people aged 12 to 15 in England will be offered one dose of the Pfizer/BioNTech COVID-19 vaccine. In line with the recommendation of the independent Joint Committee on Vaccination and Immunisation (JCVI), the government sought advice from the four UK Chief Medical Officers and has based

The French speciality vaccine company, Valneva, has announced that it has received a termination notice from the UK Government in relation to the Supply Agreement for its COVID-19 vaccine candidate, VLA2001. The UK Government has alleged that the company is in breach of its obligations under the Supply Agreement, which Valneva strenuously denies. Valneva started

The NHS has launched the world’s largest trial of a revolutionary new blood test that can detect more than 50 types of cancer before symptoms appear. The Galleri test is a simple blood test that research has shown is particularly effective at finding cancers that are typically difficult to identify early – such as head

Amgen’s first-in-class medicine Lumykras (sotorasib) has become the first new cancer therapy to receive Conditional Marketing Authorisation for use1 across England, Scotland and Wales by the Medicines and Healthcare products Regulatory Agency (MHRA) under Project Orbis. The authorisation follows a review of sotorasib’s role in treating patients with previously treated locally advanced or metastatic non-small

I’ve spent the past two decades working in marketing roles within the global pharma and biotech industry. Sexy, I know. I’ve seen my fair share of successes and failures in my time, but nothing like the past 18 months. It’s been wild. What did the pandemic do to the world of life sciences? It changed

The Prime Minister has set out plans to tackle the Covid backlogs, reform adult social care, and bring the health and social care system closer together on a long term, sustainable footing, following a £36 billion investment over the next three years. From April 2022, the government will introduce a new, UK-wide 1.25% Health and Social Care

The National Institute of Health and Care Excellence (NICE) has reconsidered its previous decision for Janssen’s Erleada®▼ (apalutamide) and published two positive Final Appraisal Determinations (FADs) recommending it for use in combination with androgen deprivation therapy (ADT) to treat prostate cancer [3,4]. Apalutamide plus ADT is recommended for two indications within its marketing authorisation: As

Last week the BBC news reported here on the NHS deal on the product inclisiran (Leqvio) 284mg/1.5ml solution for injection

The Prime Minister and Health and Social Care Secretary Sajid Javid have announced that the NHS will receive an extra £5.4 billion over the next 6 months to support its response to COVID-19 and help tackle waiting lists. The funding will immediately go towards supporting the NHS to manage the immediate pressures of the pandemic.

The National Institute for Health and Care Excellence (NICE) has recommended Novartis’ Cosentyx® (secukinumab) as an option for treating moderate to severe plaque psoriasis in children and young people people aged 6 to 17 years who have not responded to other forms of systemic treatment or for whom these options were contraindicated or not tolerated.

The Joint Committee on Vaccination and Immunisation (JCVI) is advising that people with severely weakened immune systems should have a third vaccine dose as part of their primary COVID-19 vaccination schedule. This third dose should be offered to people over 12 who were severely immunosuppressed at the time of their first or second dose, including

It is hard to imagine what Brexit might have brought if it weren’t for the pandemic. However, five years on from the UK’s vote to leave the European Union (EU), we can take stock of the post-Brexit life sciences industry; whether our hopes or fears have been realised and where the industry should turn its

Palm trees bend and sway in hurricane-force winds that could topple an oak or crack the trunk of a sturdy pine. There’s a lesson here for biopharma marketers during the planet-wide hurricane that has been COVID-19. Flexibility in the face of uncertainty is essential – especially as we transition to a new world of omnichannel

It is well established that the COVID-19 pandemic accelerated the digital evolution of the NHS by years in a matter of weeks, resulting in unprecedented changes to the way it delivers patient care, and demonstrating what is possible when there is a true sense of urgency. But how has it influenced the way the NHS

Faced with the monumental challenge of COVID-19, health and social care staff moved into crisis mode, reorganising, recalibrating, and realigning to meet the demands of a pandemic-struck nation. But what impact did this have on the shape of patient pathways, and what can we learn from the tragedy of the last 18 months? Top 5 takeaways 1 Perfect

A clear, appropriate and best practice-based patient treatment pathway is crucial. Explore how to review an existing pathway to identify improvements. At a time of immense change for the NHS, pharma has a role and responsibility in supporting this. As the NHS looks to keep patients out of hospital, reduce waiting lists and the number

As every dispenser knows, the purchase price of generics can vary month on month and from supplier to supplier. So

August Changes: Additions: Of interest are 2 entries for what were Special Order items and now have proprietary/ generic prices

This Week’s FAQ is based around Hypromellose Eye Drops and the Drug Tariff Question: Can you help me please? I

The latest Category M Drug Tariff reimbursement prices have finally been published, later than usual. And they show a lot

ADDED 2 online learning modules; An Introduction to Controlled Drugs and An Introduction to Doctor Dispensing ADDED resource section –

My name is Greg Bull and for 25+ years I have been helping dispensing doctors and I have teamed up

Formulary Development BNF 01 Gastrointestinal Products Whilst working my way through the Prescription Cost Analysis figures for a project I

Working my way through a dispensary’s monthly purchase books and comparing to the Open Exeter statement is a good way

In this PSNC podcast we explore how to learn and use influencing skills to promote community pharmacy in the changing commissioning environment. Listen to more of our podcasts via our podcast index page or subscribe through iTunes (click here for an iTunes podcast guide).  

As the NHS continues to change, LPCs need to be able to adapt to the changes and support contractors in changing times. This podcast discusses how to manage change both within and outside the LPC. Listen to more of our podcasts via our podcast index page or subscribe through iTunes (click here for an iTunes podcast guide)....

Learn more about mentoring, an adaptable skill that can be used within community pharmacy and beyond. Listen to more of our podcasts via our podcast index page or subscribe through iTunes (click here for an iTunes podcast guide).  

Led by negotiation skills trainer Phil Parry this PSNC MyCoach podcast provides tips on how to avoid failure and improve success. Supported by Pfizer Limited. Listen to more of our podcasts via our podcast index page or subscribe through iTunes (click here for an iTunes podcast guide).  

Facilitating an LPC planning meeting  or contractor meeting? This  short PSNC MyCoach podcast will sharpen skills and boost your confidence. Listen to more of our podcasts via our podcast index page or subscribe through iTunes (click here for an iTunes podcast guide).  

For new LPC chairs or experienced chairs looking for tips and ideas – a PSNC MyCoach podcast on chairing meetings, with training consultant Phil Parry. Listen to more of our podcasts via our podcast index page or subscribe through iTunes (click here for an iTunes podcast guide).  

In this PSNC podcast we discuss why LPCs are consulted on market entry applications; what if the applicant is not an existing contractor in the LPC area; what LPCs should and shouldn’t take into account when considering an application; what about distance selling applications; governance and conflicts of interests? Listen to more of our podcasts...

With Rachel Harrison who leads PSNC’s Leadership Academy. Rachel discusses the qualities she has seen in some of the LPC members and officers that single them out as potential leaders. The qualities LPC leaders possess; what make people follow leaders? Key aspects of change management and coaching; the different styles of leadership? What sort of...

Find out about the way the Community Pharmacy Assurance Framework (CPAF) – is there an obligation to complete it? The questions that are asked and how to complete them; how long do pharmacies have to return them – is there flexibility? What happens if a pharmacy doesn’t complete it? When the report has been submitted,...